Nvidia Backed This AI Drug Startup. AbbVie Just Became a Partner Before Its IPO - Yahoo Finance
Why now
Thesis: AI drug discovery gains big-pharma validation
Catalyst to watch: IPO pricing and partnership milestones
Main risk: Early-stage startup with unproven pipeline
Why it matters
AbbVie partnering with an Nvidia-backed AI drug startup validates AI-driven drug discovery ahead of its IPO.
Sources
- googlenews · news.google.com · 2026-09-23 18:42 UTC